Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Modern Pathology

• Publication date

  2014-04-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/modpathol.2014.71PMID 24762544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

  2013cited by this paper
• Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.

  2013cited by this paper
• A phase I dose-finding study of vorinostat (V) combined with capecitabine (X) and cisplatin (P) as first-line therapy in patients with advanced gastric cancer.

  2013cited by this paper
• Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.

  2013cited by this paper
• Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

  2013cited by this paper
• Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.

  2013cited by this paper
• Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.

  2012cited by this paper
• FGFR1 expression and gene copy numbers in human lung cancer

  2012cited by this paper
• Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large cell carcinoma

  2012cited by this paper
• Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

  2012cited by this paper
• FGFR1 Amplification in Squamous Cell Carcinoma of The Lung

  2012cited by this paper
• Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

  2012cited by this paper
• First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung.

  2012cited by this paper
• Molecular Pathways Molecular Pathways : Fibroblast Growth Factor Signaling : A New Therapeutic Opportunity in Cancer

  2012cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.

  2011cited by this paper
• Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.

  2011cited by this paper
• Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens

  2011cited by this paper
• Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

  2011cited by this paper
• Increased FGFR1 copy number in lung squamous cell carcinomas.

  2011cited by this paper
• Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

  2010cited by this paper
• Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

  2010cited by this paper
• Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

  2010cited by this paper
• Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

  2010cited by this paper
• Fibroblast growth factor signalling: from development to cancer

  2010cited by this paper
• The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification

  2009cited by this paper
• Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development

  2009cited by this paper
• SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas

  2009cited by this paper
• Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

  2009cited by this paper
• Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer

  2008cited by this paper
• High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications

  2007cited by this paper
• Gene amplifications associated with the development of hormone-resistant prostate cancer.

  2003cited by this paper
• Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH.

  2002cited by this paper
• High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.

  2001cited by this paper

• Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan

  2024cites this paper
• Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer

  2020cites this paper
• The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis

  2019cites this paper
• Fibroblast growth factor receptor 1 amplification in laryngeal squamous cell carcinoma

  2018cites this paper
• FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis

  2018cites this paper
• Molecular genetics of lung cancer

  2018cites this paper
• Investigating prognostic and predictive tissue biomarkers in head and neck squamous cell carcinoma

  2017cites this paper
• Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma

  2017cites this paper
• Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer

  2016influential citation
• Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.

  2016cites this paper
• The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis

  2016cites this paper
• The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis

  2016cites this paper
• Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma

  2016cites this paper
• Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy.

  2016cites this paper
• Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation

  2015cites this paper
• Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI 3 K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases

  2015cites this paper
• Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review

  2015cites this paper
• Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.

  2015cites this paper
• The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data

  2015cites this paper
• Biomarker testing in non-small cell lung carcinoma: Rationale and practical considerations

  2014cites this paper